WebSep 23, 2024 · Recurrent and/or metastatic HNSCC without indications for local radical treatment; Cohort 1: Patients who have received previous platinum-based therapy and experienced disease progression or toxic intolerance during or after treatment; Cohort 2: Patients who have received prior platinum-based therapy and immune checkpoint … WebApr 4, 2024 · This trial was registered at www.chinadrugtrials.org.cn (Number: CTR20240889). Subjects were randomly allocated in a 1:1 ratio to receive a single intravenous infusion of 4 mg/kg LZM008 or ACTEMRA ® in 60 min ± 5 min and were discharged from the Phase I clinical research center on day 4 and were required to …
Illegal drug trade in China - Wikipedia
http://lib.cpu.edu.cn/65/5c/c1197a91484/page.htm WebApr 13, 2024 · 4月12日,中国药物临床试验登记与信息公示平台显示,默沙东(MSD)已经启动了 皮下注射抗PD-1单抗 MK-3475A注射液的一项国际多中心3期临床试验的中国部分,针对适应症为 转移性非小细胞肺癌(NSCLC)一线治疗 。. 公开资料显示,MK-3475A由抗PD-1单抗帕博利珠单抗 ... paye allowances 2021/22
Safety and efficacy of SHR4640 combined with febuxostat for
WebSep 19, 2024 · Clinical trial registration: The protocols were registered on the official website of the China Food and Drug Administration (CFDA): http://www.chinadrugtrials.org.cn/ ; … WebMay 20, 2024 · 药物临床试验项目信息来源于国家药品监督管理局药品审评中心(CDE)药物临床试验登记与信息公示平台(http://www.chinadrugtrials.org.cn/index.html),2024年登记药物临床试验项目共计3268项。 其中,化学药品2372项(72.6%)、生物制品814项(24.9%)、中药/天然药物82项(2.5%),见图1。 图1:药物分类分布情况 国内多中 … WebGitHub - reycn/china-drug-trials-crawler: A web crawler for Chinadrugtrials.org.cn, written in Python 3.6+. reycn china-drug-trials-crawler master 1 branch 0 tags 9 commits Failed … paye allowances 2022